Rational Advisors’s Medifast MED Stock Holding History

Rational Advisors’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4,000	Closed	-$785K	–	211
2020 Q4	$785K	Buy	+4,000	New	+$707K	0.21%	115
2017 Q2	–	Sell	-6,800	Closed	-$302K	–	329
2017 Q1	$302K	Buy	+6,800	New	+$293K	0.2%	126

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Rational Advisors's MED Position: Q1 2021 in Review

Rational Advisors sold out of Medifast (MED) in Q1 2021, closing a stake of 4,000 shares — an estimated $785K sold.

Rational Advisors first reported a position in MED in Q1 2017 and held it in 2 quarters. The position peaked at $785K in Q4 2020. 277 funds tracked by Wall St. Rank hold MED as of Q1 2021.

Rational Advisors reported no remaining Medifast position as of Q1 2021 after selling out during the quarter.
Rational Advisors sold 4,000 Medifast shares in Q1 2021, an estimated $785K.
Rational Advisors first reported a position in Medifast in Q1 2017 and held it in 2 quarters.
Rational Advisors's Medifast position peaked at $785K in Q4 2020.
277 funds tracked by Wall St. Rank held Medifast as of Q1 2021.

Based on Rational Advisors's 13F filing for Q1 2021, filed 10 May 2021.